PD-L1 expression in non-small cell lung cancer according to specimen type; a retrospective study of over 2,000 cases by Haragan, Alexander et al.
FS Elwin(1) , A Haragan (1,2),  JR Gosney (1,2)  
Royal Liverpool University Hospital, UK(1); University of Liverpool, UK(2)  
PD-L1 expression in non-small cell lung cancer according to specimen type; a retrospective study of 
over 2,000 cases   
Background:  
Assessing expression of programmed-death ligand-1 (PD-L1) on tumour cell membranes by 
immunochemistry is an important complementary or companion diagnostic test to guide the use of 
immune modulating drugs in the treatment of non-small cell lung cancer (NSCLC).   It is generally 
assumed that expression of PD-L1 is the same irrespective of the type of specimen being assessed, 
but this this does not seem to have been formally investigated in a large series of specimens 
obtained by a range of sampling methods.  Any such variation might have important practical 
implications when using PD-L1 expression levels to guide management.  
Method:  
We retrospectively compared the level of PD-L1 expression categorised as <1, 1-49 or ≥50% in 2,016 
consecutive specimens of NSCLC assessed in our laboratory divided according to specimen type 
(bronchial washings and brushings, aspirates, tissue biopsy, resection).  Adequacy (≥100 viable 
tumour cells) and tumour type were recorded also.  
Results:  
 N % PD-L1 TPS: <1% (%) 1-49% (%) ≥50% (%) Inadequate (%) 
Total 2016  100 32 30 31 7 
Specimen Type       
Biopsies 1241 62 31 32 31 7 
Aspirates 694 34 34 26 32 8 
Resections 61 3 43 23 34 0 
Washings and 
brushings 20 1 40 30 15 15 
Morphology       
Adenocarcinoma 1132 56 33 28 31 8 
Squamous 
carcinoma 695 34 31 34 29 5 
Adenosquamous 
carcinoma 13 <1 23 23 38 15 
NSCLC-NOS 161 8 30 24 36 10 
Other 15 <1 47 7 47 0 
 
Discussion: 
There was excellent consistency of PD-L1 expression levels across three of the four different 
specimen types, the only notable difference being in the relatively small group of bronchial washings 
and brushings.  These were also more often inadequate than were other types of specimen.  This is 
an important and reassuring observation, since any variation attributable to merely how a tumour is 
sampled would have serious implications when relying on this information to inform management.  
It is gratifying also that ’cytology’ specimens were equivalent to ‘histology’ specimens in terms of 
both consistency of PD-L1 expression and adequacy. 
